Praxis Precision Medicines, Inc. (PRAX) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Praxis Precision Medicines reported revenue of $0, down 100.0% from $8.6M the year before. Net income was -$303.3M, or -$13.48 per diluted share. Operating activities generated -$249.1M of cash, leaving -$249.1M of free cash flow. At fiscal year end, Praxis Precision Medicines held $937.9M in total assets against $59.8M in total liabilities, including $357.3M of cash and equivalents.
Open the full interactive Praxis Precision Medicines financials → Quarterly statements, key ratios, valuation history and price charts.
Praxis Precision Medicines Key Stats
| Share Price | $243.34 |
|---|---|
| Market Cap | $7.09B |
| Revenue YoY Growth | -100.0% |
| 52-Week Range | $52.34 – $386.33 |
| Shares Outstanding | 29.1 million (basic, 2026 Q2) |
Praxis Precision Medicines Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $2.4M | $8.6M | $0 |
| Operating Income | -$62.0M | -$167.3M | -$215.0M | -$126.4M | -$200.2M | -$326.2M |
| Pre-Tax Income | -$61.8M | -$167.1M | -$214.0M | -$123.3M | -$182.8M | -$302.8M |
| Income Tax | -$8,000 | $0 | — | — | — | $471,000 |
| Net Income | -$61.8M | -$167.1M | -$214.0M | -$123.3M | -$182.8M | -$303.3M |
| Diluted EPS | -$117.90 | -$59.10 | -$69.60 | -$18.69 | -$10.21 | -$13.48 |
Praxis Precision Medicines Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$73.9M | -$88.9M | -$92.6M | -$83.7M |
| Diluted EPS | -$3.36 | -$3.95 | -$3.20 | -$2.87 |
Praxis Precision Medicines Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $296.6M | $138.7M | $61.6M | $81.3M | $215.4M | $357.3M |
| Current Assets | $302.3M | $287.4M | $110.8M | $84.9M | $404.4M | $610.9M |
| Total Assets | $303.2M | $292.7M | $115.1M | $87.9M | $483.1M | $937.9M |
| Current Liabilities | $15.7M | $38.4M | $34.3M | $15.7M | $37.5M | $59.8M |
| Total Liabilities | $15.7M | $41.9M | $39.0M | $18.3M | $37.7M | $59.8M |
| Shareholders' Equity | $287.5M | $250.8M | $76.1M | $69.7M | $445.4M | $878.1M |
Praxis Precision Medicines Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$52.6M | -$124.6M | -$185.0M | -$111.1M | -$131.8M | -$249.1M |
| Cash From Investing | $0 | -$140.5M | $96.9M | $39.0M | -$248.5M | -$311.1M |
| Cash From Financing | $304.4M | $107.6M | $10.5M | $91.9M | $514.3M | $702.2M |
| Free Cash Flow | -$52.6M | -$125.6M | -$185.5M | -$111.2M | -$131.8M | -$249.1M |
Figures from Praxis Precision Medicines' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Praxis Precision Medicines financials page for every line item.
Praxis Precision Medicines Company Profile
| Ticker | PRAX |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Boston, Massachusetts |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001689548 |
Frequently Asked Questions
What was Praxis Precision Medicines' revenue in fiscal 2025?
Praxis Precision Medicines (PRAX) reported revenue of $0 for fiscal 2025.
What is Praxis Precision Medicines' annual revenue history?
Praxis Precision Medicines' annual revenue by fiscal year: 2020: $0; 2021: $0; 2022: $0; 2023: $2.4M; 2024: $8.6M; 2025: $0.
What was Praxis Precision Medicines' net income in fiscal 2025?
Praxis Precision Medicines reported net income of -$303.3M for fiscal 2025.
What was Praxis Precision Medicines' earnings per share (EPS) in fiscal 2025?
Praxis Precision Medicines' diluted EPS was -$13.48 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Praxis Precision Medicines generate in fiscal 2025?
Praxis Precision Medicines generated -$249.1M of free cash flow in fiscal 2025.
What was Praxis Precision Medicines' revenue last quarter?
In its most recent reported quarter (2026 Q2), Praxis Precision Medicines reported revenue of $0.
How many shares of Praxis Precision Medicines are outstanding?
Praxis Precision Medicines reported a weighted average of 29.1 million basic shares outstanding in 2026 Q2.
What is Praxis Precision Medicines' market cap?
Based on its latest closing price, Praxis Precision Medicines (PRAX) has a market capitalization of about $7.09B.
When does Praxis Precision Medicines' fiscal year end?
Praxis Precision Medicines' fiscal year end, as registered with the SEC, is December 31.
Where is Praxis Precision Medicines headquartered?
Praxis Precision Medicines lists its business address in Boston, Massachusetts in its SEC filings.